
SGN Tech Solutions | we provide white label gaming solutions
SGN Tech Solutions is a Canadian company that provides B2B and B2C gaming solutions at the crossroads of entertainment and technology.
Specifications | Milorganite
Size Guide Number (SGN) and Uniformity Index (UI) The Size Guide Number and Uniformity Index both accurately define the size of a fertilizer. SGN is the average millimeter (mm) diameter of that fertilizer. The Uniformity Index defines how …
Trial in Progress: Open-Label Phase 1 Study to Evaluate Safety of SGN …
2024年11月5日 · SGN35C-001 (NCT06254495) is a first-in-human, open-label, multicenter, global, phase 1 dose-escalation and dose-expansion study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and antitumor activity of SGN-35C in patients with select relapsed/refractory (R/R) lymphomas.
Phase 1 study of SGN-BB228, an investigational CD228 x 4-1BB ...
2023年5月31日 · Methods: SGNBB228-001 (NCT05571839) is a phase 1, open label, multicenter study designed to evaluate the safety, tolerability, PK, and antitumor activity of SGN-BB228 in adults ≥18 years of age with advanced melanoma or other solid tumors.
Trial in Progress: Open-Label Phase 1 Study to Evaluate Safety of SGN …
2024年11月5日 · SGN35C-001 (NCT06254495) is a first-in-human, open-label, multicenter, global, phase 1 dose-escalation and dose-expansion study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and antitumor activity of SGN-35C in patients with select relapsed/refractory (R/R) lymphomas.
PF-08046050 / Sanofi, Pfizer - LARVOL
An open-label phase 1 study to investigate SGN-CEACAM5C in adults with advanced solid tumors (SGNCEA5C-001, Trial in Progress) (AACR 2024) - P1 | "Safety and antitumor activity endpoints will be summarized using descriptive statistics. Recruitment is …
SGN228-001: A phase I open-label dose-escalation, and …
2020年5月25日 · Methods: SGN228-001 (NCT04042480) is a phase 1, open label, multicenter, dose escalation, and expansion study enrolling up to 240 subjects to evaluate the safety, tolerability, PK, and antitumor activity of SGN-CD228A in select advanced solid tumors.
SGN-CEACAM5C is a novel in-vestigational antibody-drug conjugate (ADC) directed to CEACAM5 composed of the human-ized immunoglobulin G (IgG1) anti-CEACAM5 monoclonal antibody tusamitamab chemically conjugated to 8 molecules of the topoisomerase 1 inhibitor 7-aminomethyl-10,11-methylenedioxycamptothecin (AMDCPT).
Armament Lime is a patent pending high-calcium fertilizer enhanced with a fully biodegradable, proprietary anionic amino acid polymer. Use when soil tests suggest calcium amendments due to low calcium levels or an imbalance of cations in the soil.
A Phase 1 Study of SGN-35T in People with Lymphoma
Researchers want to find the best dose of SGN-35T to use in people with lymphoma. The people in this study have Hodgkin or non-Hodgkin lymphoma that came back or keeps growing after treatment. Many lymphoma cells have a protein called CD30 on their surfaces. This protein plays a role in cancer growth.
- 某些结果已被删除